Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
BLB-01D1 by Bristol-Myers Squibb for Non-Small Cell Lung Cancer: Likelihood of Approval
BLB-01D1 is under clinical development by Bristol-Myers Squibb and currently in Phase I for Non-Small Cell Lung Cancer. According to...
BLB-01D1 by Bristol-Myers Squibb for Non-Small Cell Lung Cancer: Likelihood of Approval
BLB-01D1 is under clinical development by Bristol-Myers Squibb and currently in Phase I for Non-Small Cell Lung Cancer. According to...
BLB-01D1 by Systimmune for Esophageal Squamous Cell Carcinoma (ESCC): Likelihood of Approval
BLB-01D1 is under clinical development by Systimmune and currently in Phase III for Esophageal Squamous Cell Carcinoma (ESCC). According to...